The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation
, 50 , 1-13, doi: Koyani, C
Intended Use For laboratory research only
Practical applications may differ from labeled uses, but understanding the regulatory context remains important
Special Considerations for Bariatric and Stomach Procedures If your upcoming surgery involves your stomach or gastrointestinal tractsuch as gastric bypass, gastric sleeve, or endoscopyyour surgical team may recommend stopping semaglutide 5 to 7 days beforehand
As you know, different devices have different power demands